Table of Contents

company-logo

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to non-affiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.

American Bio Medica Dividend Announcement

• American Bio Medica does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on American Bio Medica dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

American Bio Medica Dividend History

American Bio Medica Dividend Yield

American Bio Medica current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing American Bio Medica stock? Use our calculator to estimate your expected dividend yield:

American Bio Medica Financial Ratios

P/E ratio0.00
PEG ratio0.00
P/B ratio0.00
ROE0.00%
Payout ratio0.00%
Current ratio0.00
Quick ratio0.00
Cash Ratio0.00

American Bio Medica Dividend FAQ

Does American Bio Medica stock pay dividends?
American Bio Medica does not currently pay dividends to its shareholders.
Has American Bio Medica ever paid a dividend?
No, American Bio Medica has no a history of paying dividends to its shareholders. American Bio Medica is not known for its dividend payments.
Why doesn't American Bio Medica pay dividends?
There are several potential reasons why American Bio Medica would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will American Bio Medica ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While American Bio Medica has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is American Bio Medica a dividend aristocrat?
American Bio Medica is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is American Bio Medica a dividend king?
American Bio Medica is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is American Bio Medica a dividend stock?
No, American Bio Medica is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy American Bio Medica stocks?
To buy American Bio Medica you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy American Bio Medica stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.